There has been growing interest in implementation of pragmatic approaches in clinical trials. Especially for enhancement cancer research conduct including regulatory communications and ultimately patient care, where the use of…
Continue readingThe last year has been very successful for our team. We are grateful that in such challenging times for many businesses, we had the opportunity to set up and manage…
Continue readingI was excited to attend the Oncology Professional Care Conference at the ExCeL Conference Centre in London from 23rd to 24th May 2023, as I’d not been to a conference…
Continue readingOn 16 to 18th of March 2023 was the Annual Meeting of the Japanese Society of Medical Oncology known as JSMO 2023. This is one of the big oncology meetings…
Continue readingAccording to statistics back in 2012 there were approximately 981 drugs in development for cancer and this statistic is probably higher now. Some of the main challenges are how to…
Continue readingIn order to identify the correct dose of any therapeutic agent there are 2 pharmacological phases: Pharmacokinetic phase in which the dose, dosage form, frequency, and route of administration are…
Continue readingTumours crate environment in which all cells are involved in supporting tumour progression. The formation of tumour cell takes many years during which the cell generate transformation that will allow…
Continue readingT cell-directed cytokine therapy has shown very promising results in some patients with leukaemia. These results in combination with some animal model data gives a big hope that T cells…
Continue readingDuring the recent years scientists have discovered more details about cellular genomes, gene mutations and mechanisms involved in cancer development and spreading. This led to hopes that soon there will…
Continue readingWe often see in the news headlines information of some drug being potentially carcinogenic or contaminated with substance that is potentially carcinogenic. But what that means and how do we…
Continue reading